Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass

• Published in: JVS-vascular science Vol. 4; p. 100092
• Main Authors: Gutowski, Piotr, Guziewicz, Malgorzata, Ilzecki, Marek, Kazimierczak, Arkadiusz, Lawson, Jeffrey H., Prichard, Heather L., Przywara, Stanislaw, Samad, Rabih, Tente, William, Turek, Jakub, Witkiewicz, Wojcieh, Zapotoczny, Norbert, Zubilewicz, Tomaz, Niklason, Laura E.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.01.2023; Elsevier
• Subjects: Arterial reconstruction; Bioengineered blood vessel; Human acellular vessel; Long-term outcomes; Peripheral artery disease; Long-term outcomes; Peripheral artery disease; Human acellular vessel; Arterial reconstruction; Bioengineered blood vessel

The human acellular vessel (HAV) was evaluated for surgical bypass in a phase II study. The primary results at 24 months after implantation have been reported, and the patients will be evaluated for ≤10 years. In the present report, we have described the 6-year results of a prospective, open-label,...